Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers.

However, both mTRAIL–CDK9i combination treatments, i.e., mTRAIL–dinaciclib and mTRAIL–NVP-2, achieved a highly significant in vivo anti-tumor effect (Fig. 2e ).

also in 132,142 other papers